Circ_CHFR promotes PDGF-BB-induced proliferation, invasion and migration in VSMCs via miR-149-5p/NRP2 axis.
- Meixue Wang, Chengliang Li, Tianzhi Cai, Anji Zhang, Jinlong Cao, H. Xin
- BiologyJournal of Cardiovascular Pharmacology
- 10 May 2021
Circ_CHFR promoted the proliferation, invasion and migration of PDGF-BB-induced HVSMCs via miR-149-5p/NRP2 axis, providing a new insight into the pathogenesis of AS and a potential therapeutic target for AS treatment.
LncRNA TNK2‐AS1 regulated ox‐LDL‐stimulated HASMC proliferation and migration via modulating VEGFA and FGF1 expression by sponging miR‐150‐5p
- Tianzhi Cai, Xiuzhen Cui, Kelin Zhang, Anji Zhang, Baixue Liu, J. Mu
- BiologyJournal of Cellular and Molecular Medicine
- 29 August 2019
The expression of lncRNA TNK2 antisense RNA 1 in oxidized low‐density lipoprotein (ox‐LDL)‐stimulated human aortic smooth muscle cells (HASMCs) and the mechanistic role ofTNK2‐AS1 in the proliferation and migration of HASMCs were determined.
miR-379 Inhibits Cell Proliferation, Invasion, and Migration of Vascular Smooth Muscle Cells by Targeting Insulin-Like Factor-1
- Kai Li, Yong Wang, Anji Zhang, Baixue Liu, Li Jia
- BiologyYonsei medical journal
- 7 November 2016
The results suggest that miR-379 plays an important role in regulating VSMCs proliferation, invasion, and migration by targeting IGF-1.
Unc-51 like autophagy activating kinase 1 accelerates angiotensin II-induced cardiac hypertrophy through promoting oxidative stress regulated by Nrf-2/HO-1 pathway.
- Anji Zhang, Meixue Wang, Pengzhan Zhuo
- Biology, ChemistryBiochemical and Biophysical Research…
- 29 January 2019
Comparative Effectiveness and Safety of Ticagrelor Versus Clopidogrel for Elderly Chinese Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Retrospective Cohort Study
- Suining Xu, Ying-zi Liang, K. Lian
- Medicine, BiologyDrugs & Aging
- 23 August 2022
Ticagrelor was associated with a lower incidence of major adverse cardiovascular events than clopidogrel at 12 months in elderly Chinese patients with coronary artery disease, without a significant increase of Bleeding Academic Research Consortium bleeding events.